The existence of this sort of dynamic receptor regulation is well described with histamine (H2)-receptor antagonists and explains the development of tolerance in peptic ulcer disease and rebound acid hypersecretion on drug withdrawal. This evidence concerns the gene HRH2 and peptic ulcer disease.